Electrification And Reshoring Will Unlock New Medical Manufacturing Avenues
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
01 Jun 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
US$24.00
17.0% undervalued intrinsic discount08 Aug
US$19.92
1Y
-2.1%7D
9.1%